Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal NeoVascularization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03024424
What this trial is testing

Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD

Who this might be right for
Age-Related Macular DegenerationChoroidal NeovascularizationGenetic Counseling
University of Utah 16
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Not applicableStudy completedNCT03897192
What this trial is testing

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Who this might be right for
Punctate Inner Choroidopathy
Changhua Christian Hospital 14
Large-scale testing (Phase 3)Ended earlyNCT01402544
What this trial is testing

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 20
Not applicableStudy completedNCT00748384
What this trial is testing

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 30
Early research (Phase 1)Study completedNCT00008515
What this trial is testing

Fluocinolone Implant to Treat Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 16
Not applicableLooking for participantsNCT02141308
What this trial is testing

OCT in Rare Chorioretinal Diseases

Who this might be right for
Retinal Artery OcclusionsPolypoidal Choroidal VasculopathyRetinal Arterial Macroaneurysm+2 more
Oregon Health and Science University 150
Not applicableUnknownNCT05639660
What this trial is testing

Clinical Implication of Aflibercept in PCV Treatment in China

Who this might be right for
Polypoidal Choroidal Vasculopathy
Peking Union Medical College Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT01840410
What this trial is testing

Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.

Who this might be right for
Choroidal Neovascularization (CNV)
Novartis Pharmaceuticals 183
Testing effectiveness (Phase 2)Study completedNCT00239928
What this trial is testing

Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 61
Early research (Phase 1)Study completedNCT00407719
What this trial is testing

Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationDegenerative MyopiaPathological Myopia
Johns Hopkins University 10
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Not applicableStudy completedNCT00596388
What this trial is testing

Usage of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07365371
What this trial is testing

A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 174
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Testing effectiveness (Phase 2)UnknownNCT04922151
What this trial is testing

601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

Who this might be right for
Pathological Myopic Choroidal Neovascularization
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Post-approval studies (Phase 4)UnknownNCT02092532
What this trial is testing

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)

Who this might be right for
Neovascular Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Large-scale testing (Phase 3)Ended earlyNCT00417833
What this trial is testing

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Who this might be right for
Diabetic Proliferative RetinopathyVascular Vein OclussionChoroidal Neovascularization
Asociación para Evitar la Ceguera en México
Next Page